Nomination in the Scientists' Choice Awards with DRG´s Salivary Hepcidin ELISA |
 |
||
DRG is honoured to inform that our Salivary Hepcidin assay has been nominated by clinical professionals in the SelectScience Scientists' Choice Awards for Best New Clinical Product of 2018.
About Salivary Hepcidin ELISA:
Analysis of metabolites found in saliva is a favorable diagnostic solution, as it can be obtained by methods sample collection methods which are both a non-invasive and stress-free. Tools such as the DRG Salivary Hepcidin ELISA (SLV-6082) can be used for the quantification of metabolites such as Hepcidin in a standardized, precise and efficient way.
Vote for us:
Voting for this award opened already on Friday, June 7! We would like to invite all to vote, via an online survey, for the winners of Best New Clinical Products of 2018 from the shortlist.
Voting closes on Friday July 26 and the winner will be announced at a special Scientists' Choice Awards® party during the AACC 2019 Scientific Meeting & Clinical Lab Expo in Anaheim, CA, USA, on Tuesday August 6, 2019.
